Related Experiment Video
Updated: Dec 30, 2025

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
Prognostic impact of body mass index on in-hospital bleeding complications after ST-segment elevation myocardial
Delphine Ingremeau1, Sylvain Grall1, Florine Valliet2
1Department of Cardiology, Angers University Hospital, Angers 49933, France.
Insights
Normal weight patients experiencing ST-elevation myocardial infarction (STEMI) face higher bleeding risks and worse survival rates. This suggests increased vulnerability to bleeding complications in this patient group after STEMI.
Area of Science:
- Cardiology
- Clinical Research
- Obesity Medicine
Background:
- ST-elevation myocardial infarction (STEMI) is a leading cause of mortality despite advanced treatments.
- Individualized patient management is crucial for improving outcomes after STEMI.
- The role of in-hospital bleeding complications in STEMI prognosis warrants further investigation.
Purpose of the Study:
- To investigate the association between in-hospital bleeding complications and prognosis in patients with STEMI.
- To explore whether body mass index (BMI) influences the impact of bleeding complications on STEMI outcomes.
Main Methods:
- Prospective inclusion of 2070 STEMI patients from January 2005 to December 2012 in the "Registre d'Infarctus Maine-Anjou" cohort.
- Recording of Bleeding Academic Research Consortium (BARC) in-hospital bleeding complications.
- Analysis of one-year cardiovascular mortality stratified by BMI categories (normal weight, overweight, obese).
Main Results:
- One-year cardiovascular mortality was significantly higher in normal weight patients (BMI < 25 kg/m²) compared to overweight or obese patients (BMI ≥ 25 kg/m²).
- A significant interaction was observed between BARC 3 bleeding events and BMI groups regarding mortality.
- Normal weight patients experiencing BARC 3 bleeding had a substantially worse prognosis than overweight or obese patients with similar bleeding events.
Conclusions:
- Normal weight patients exhibit higher rates of in-hospital bleeding complications following STEMI.
- Lower survival rates in normal weight STEMI patients may be attributed to a greater vulnerability to bleeding complications.
- Body weight, specifically normal weight, is a critical factor influencing STEMI prognosis in the context of bleeding events.
Background:
ST-elevation myocardial infarction (STEMI) remains a major cause of mortality despite early revascularization and optimal medical therapy. Tailoring individual management by considering patients' specificities may help in improving post-STEMI survival.
Aim:
To evaluate whether in-hospital bleeding complications may be involved in post STEMI prognosis among overweight patients.
Methods:
We prospectively included 2070 patients with a STEMI between January 2005 and December 2012 in the French observational cohort, "Registre d'Infarctus Maine-Anjou". Bleeding Academic Research Consortium (BARC) in-hospital bleeding complications were recorded.
Results:
Of 705 patients (35.3%) were presented as being of normal weight, defined as a body mass index (BMI) < 25 kg/m², 877 (43.9%) had a BMI between 25 and 30 kg/m² and 416 (20.8%) had a BMI ≥ 30 kg/m². One-year cardiovascular mortality was lower for BMI ≥ 25 kg/m² (5.3% and 7.1%) patients than for normal weight patients (10.8%) (P = 0.001). We found an interaction between the effect of BARC 3 on mortality and BMI groups. While a BARC 3 was related to a higher 1-year mortality in general (HR: 2.58, 95%CI: 1.44-4.64, P ≤ 0.001), prognosis was even worse in normal weight patients (HR: 2.97, 95%CI: 1.61-5.5, P < 0.001) than for patients with a BMI ≥ 25 kg/m² (HR: 1.94, 95%CI: 1.02-3.69, P = 0.041).
Conclusion:
Normal weight patients presented higher rates of in-hospital bleeding complications and lower survival after a STEMI. Excess mortality might be due to greater vulnerability to bleeding amongst normal weight patients.
More Related Videos
05:16Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
Published on: June 10, 2025
05:26Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction
Published on: May 28, 2019
Related Concept Videos
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Myocarditis I: Introduction
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome IV: Interprofessional Care
Obesity